- Cordex Biologics, an ExCellThera company, is actively seeking strategic partnerships to accelerate the commercialization of Zemcelpro® in Europe and other markets MONTREAL, August 27, 2025 ...
Pharmaceutical Technology on MSN
EC approves Roche’s Gazyva to treat active lupus nephritis
Roche has received approval from the European Commission (EC) for its humanised monoclonal antibody Gazyva/Gazyvaro ...
Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.
Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes. A phase I/II open-label clinical trial of CPI-613 in combination with modified FOLFIRINOX in ...
ENGLEWOOD CLIFFS, N.J.--(BUSINESS WIRE)--Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biotechnology company, announced today that the Company has filed for Breakthrough Therapy designation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback